Novo Nordisk sues Eli Lilly over advertising
It’s a legal battle between weight-loss drug heavyweights the maker of Wegovy is suing Zepbound manufacturer Eli Lilly.
Eli Lilly
CVS to add weight-loss options to drug plans
CVS is adding two weight-loss options to its drug plans.
Eli Lilly signs deal to make, sell drugs discovered by AI
The maker of popular GLP-1 drugs Zepbound and Mounjaro could soon be making and selling drugs discovered by Ai.
FDA to remove suicide warnings for weight loss drugs
The FDA wants suicide warnings to be taken off of some popular weight-loss medications.
Eli Lily cuts price for Zepbound
A drug that helps people lose weight now has a slimmer price tag.
Weight loss pill seeks approval
Eli Lilly says it will file for regulatory approval for its GLP1 weight loss pill called Orforglipron.
Eli Lilly cuts insulin prices up to 70% amid pressure to slash costs
The move follows criticism from federal lawmakers and advocacy groups.
The move follows criticism from federal lawmakers and advocacy groups.
